Tang H, Liu S, Yan X, Jin Y, He X, Huang H
Biology (Basel). 2023; 12(9).
PMID: 37759607
PMC: 10525126.
DOI: 10.3390/biology12091208.
Wan L, Li W, Meng Y, Hou Y, Chen M, Xu B
Front Immunol. 2022; 13:849451.
PMID: 35514959
PMC: 9063412.
DOI: 10.3389/fimmu.2022.849451.
Maimaitiyiming Y, Ye L, Yang T, Yu W, Naranmandura H
Int J Mol Sci. 2022; 23(8).
PMID: 35457264
PMC: 9033105.
DOI: 10.3390/ijms23084442.
Yang J, Yang Y
Bioengineered. 2022; 13(3):6409-6419.
PMID: 35220878
PMC: 8974199.
DOI: 10.1080/21655979.2022.2044249.
Buratin A, Paganin M, Gaffo E, Molin A, Roels J, Germano G
Blood Adv. 2020; 4(23):5902-5914.
PMID: 33259601
PMC: 7724907.
DOI: 10.1182/bloodadvances.2020002337.
Long non-coding RNA AWPPH interacts with ROCK2 and regulates the proliferation and apoptosis of cancer cells in pediatric T-cell acute lymphoblastic leukemia.
Li X, Song F, Sun H
Oncol Lett. 2020; 20(5):239.
PMID: 32973953
PMC: 7509509.
DOI: 10.3892/ol.2020.12102.
Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia.
Barcenas-Lopez D, Nunez-Enriquez J, Hidalgo-Miranda A, Beltran-Anaya F, May-Hau D, Jimenez-Hernandez E
Genes (Basel). 2020; 11(3).
PMID: 32183133
PMC: 7140896.
DOI: 10.3390/genes11030302.
Finding ARIEL under the sea of T-ALL circuits.
Chiang M
Blood. 2019; 134(3):219-221.
PMID: 31320362
PMC: 6639983.
DOI: 10.1182/blood.2019001584.
The enhancer RNA activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia.
Tan S, Leong W, Ngoc P, Tan T, Bertulfo F, Lim M
Blood. 2019; 134(3):239-251.
PMID: 31076442
PMC: 8212351.
DOI: 10.1182/blood.2018874503.
A critical regulator of Bcl2 revealed by systematic transcript discovery of lncRNAs associated with T-cell differentiation.
Saadi W, Kermezli Y, Dao L, Mathieu E, Santiago-Algarra D, Manosalva I
Sci Rep. 2019; 9(1):4707.
PMID: 30886319
PMC: 6423290.
DOI: 10.1038/s41598-019-41247-5.
The transcriptomic profile of CD138 cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged.
Storti P, Agnelli L, Palma B, Todoerti K, Marchica V, Accardi F
Haematologica. 2019; 104(10):e465-e469.
PMID: 30846495
PMC: 6886434.
DOI: 10.3324/haematol.2018.209999.
Differential gene expression analysis tools exhibit substandard performance for long non-coding RNA-sequencing data.
Takele Assefa A, De Paepe K, Everaert C, Mestdagh P, Thas O, Vandesompele J
Genome Biol. 2018; 19(1):96.
PMID: 30041657
PMC: 6058388.
DOI: 10.1186/s13059-018-1466-5.
A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
Verboom K, Van Loocke W, Volders P, Decaesteker B, Avila Cobos F, Bornschein S
Haematologica. 2018; 103(12):e585-e589.
PMID: 29954933
PMC: 6269303.
DOI: 10.3324/haematol.2018.190587.
Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Ngoc P, Tan S, Tan T, Chan M, Li Z, Yeoh A
Leukemia. 2018; 32(10):2138-2151.
PMID: 29654272
PMC: 8197659.
DOI: 10.1038/s41375-018-0110-4.
Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing.
Wallaert A, Van Loocke W, Hernandez L, Taghon T, Speleman F, Van Vlierberghe P
Sci Rep. 2017; 7(1):7901.
PMID: 28801656
PMC: 5554241.
DOI: 10.1038/s41598-017-08148-x.
Comprehensive Analysis of MILE Gene Expression Data Set Advances Discovery of Leukaemia Type and Subtype Biomarkers.
Labaj W, Papiez A, Polanski A, Polanska J
Interdiscip Sci. 2017; 9(1):24-35.
PMID: 28303531
PMC: 5366179.
DOI: 10.1007/s12539-017-0216-9.
T-ALL and thymocytes: a message of noncoding RNAs.
Wallaert A, Durinck K, Taghon T, Van Vlierberghe P, Speleman F
J Hematol Oncol. 2017; 10(1):66.
PMID: 28270163
PMC: 5341419.
DOI: 10.1186/s13045-017-0432-0.
The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
Ha V, Luong A, Li F, Casero D, Malvar J, Kim Y
Leukemia. 2017; 31(11):2503-2514.
PMID: 28232744
PMC: 5599326.
DOI: 10.1038/leu.2017.70.
The genetics and molecular biology of T-ALL.
Girardi T, Vicente C, Cools J, De Keersmaecker K
Blood. 2017; 129(9):1113-1123.
PMID: 28115373
PMC: 5363819.
DOI: 10.1182/blood-2016-10-706465.
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
Peirs S, Frismantas V, Matthijssens F, Van Loocke W, Pieters T, Vandamme N
Leukemia. 2017; 31(10):2037-2047.
PMID: 28074072
DOI: 10.1038/leu.2017.10.